Liftstream is an executive search recruitment company in the life sciences sector
Five Resolutions for Nominations Committees to Improve Board Performance
The New Year brings a period of reflection, what will you change in the year ahead and how will you do it? There are some clear ways in which the effectiveness of the board can be improved by the way in which the nominations and governance committee discharge their responsibilities. Here we listed 5 resolutions for an effective nominations committee. Click the following links to read detailed articles on each recommendation.
MorphoSys partners to access GPCR-Targeting tech
MorphoSys based out of Munich and G7 Therapeutics AG of Zurich announced today that they have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors (GPCRs) and potentially other disease-related transmembrane proteins such as ion channels. Under the terms of the agreement, G7 Therapeutics will generate a set of disease-relevant receptors proposed by MorphoSys. MorphoSys will then apply its proprietary Ylanthia antibody library to discover and develop antibody therapeutics against these receptors. MorphoSys has the right to sublicense to third parties the access to these targets in conjunction with therapeutic antibody candidates.Dr. Marlies Sproll, Chief Scientific Officer of MorphoSys AG, commented: “G7 Therapeutics’ approach using directed evolution technologies broadens our existing development capabilities in this innovative area of research. High quality therapeutic antibodies targeting GPCRs and other transmembrane molecules represent a promising addition to our proprietary development pipeline.”
Pfizer and Merck collaborate for cancer immunotherapy
Authored by James Sheppard
How can biotech enhance executive leadership?
Take our short survey and participate in a global gender diversity study
Working in biotech, pharma or venture capital?
Immatics receives final 22m Euro Tranche of Series D funding
Authored by James Sheppard
European biotech clusters must attract executive talent or seek new leaders
Authored by Karl Simpson
Merck Serono continues impressive standard in gender diversity
Authored by Karl Simpson
immatics bags $46m for Phase III cancer vaccine
Authored by James Sheppard